dodecylphosphocholine has been researched along with betadex in 2 studies
| Studies (dodecylphosphocholine) | Trials (dodecylphosphocholine) | Recent Studies (post-2010) (dodecylphosphocholine) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
|---|---|---|---|---|---|
| 362 | 0 | 129 | 8,785 | 97 | 4,452 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carballo, D; McInally, K; Normand, P; Piché, C; Reno, FE; Silo, S; Stotland, P; Triest, M | 1 |
| Ceriani, V; Pontiroli, AE | 1 |
1 review(s) available for dodecylphosphocholine and betadex
| Article | Year |
|---|---|
Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; beta-Cyclodextrins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Compounding; Emergency Treatment; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Phosphorylcholine; Powders; Severity of Illness Index | 2018 |
1 other study(ies) available for dodecylphosphocholine and betadex
| Article | Year |
|---|---|
A novel nasal powder formulation of glucagon: toxicology studies in animal models.
Topics: Administration, Intranasal; Animals; Area Under Curve; beta-Cyclodextrins; Body Weight; Dogs; Female; Glucagon; Humans; Lung; Male; Metabolic Clearance Rate; Models, Animal; Organ Size; Phosphorylcholine; Powders; Rabbits; Rats, Sprague-Dawley; Species Specificity; Survival Analysis; Time Factors; Toxicity Tests | 2015 |